Stock DNA
Tour, Travel Related Services
CAD 46 Million ()
NA (Loss Making)
NA
0.00%
-0.00
-72.08%
4.61
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Apr 2025)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.41%
0%
-7.41%
6 Months
4.17%
0%
4.17%
1 Year
-3.85%
0%
-3.85%
2 Years
72.41%
0%
72.41%
3 Years
194.12%
0%
194.12%
4 Years
150.0%
0%
150.0%
5 Years
51.52%
0%
51.52%
KDA Group, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-64.37%
EBIT Growth (5y)
-229.08%
EBIT to Interest (avg)
-2.32
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.39
Tax Ratio
1.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.38%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.52
EV to EBIT
-5.83
EV to EBITDA
-9.75
EV to Capital Employed
4.52
EV to Sales
45.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-77.47%
ROE (Latest)
-72.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ
Apr'25
Jan'25
Change(%)
Net Sales
0.00
0.10
-100.00%
Operating Profit (PBDIT) excl Other Income
-1.30
-1.30
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.00
-2.10
4.76%
Operating Profit Margin (Excl OI)
-158,553.50%
-26,430.20%
-13,212.33%
USD in Million.
Net Sales
QoQ Growth in quarter ended Apr 2025 is -100.00% vs 0.00% in Jan 2025
Consolidated Net Profit
QoQ Growth in quarter ended Apr 2025 is 4.76% vs 12.50% in Jan 2025
Annual Results Snapshot (Consolidated) - Jul'24
Jul'24
Jul'23
Change(%)
Net Sales
0.10
0.20
-50.00%
Operating Profit (PBDIT) excl Other Income
-3.10
-2.70
-14.81%
Interest
0.20
1.40
-85.71%
Exceptional Items
-1.50
7.20
-120.83%
Consolidate Net Profit
-7.50
0.60
-1,350.00%
Operating Profit Margin (Excl OI)
-32,644.10%
-20,538.50%
-1,210.56%
USD in Million.
Net Sales
YoY Growth in year ended Jul 2024 is -50.00% vs 0.00% in Jul 2023
Consolidated Net Profit
YoY Growth in year ended Jul 2024 is -1,350.00% vs 106.67% in Jul 2023
About KDA Group, Inc. 
KDA Group, Inc.
Tour, Travel Related Services
KDA Group Inc, formerly AlliancePharma Inc, is a Canada-based company, which provides solutions and services to the pharmaceutical market. The Company operates in two segments: Pharmacy Services and Pharmaceutical Solutions. The Pharmacy services segment provides a range of services to pharmacies and pharmacists, including staffing, generic medication and related services. The Pharmaceutical Solutions segment provides a range of medical communications, training and other services to pharmaceutical companies in Canada. The Company holds interests in Pharmapar Inc., a generic pharmaceutical distribution company, and Agence L.I.V. Inc., a medical communication agency. The Company's subsidiaries include Campus Elitis Pharma Inc., Elitis Pharma Inc., Alliance Pharma Operations Inc., 9277396 Canada Inc., 9321-5317 Quebec Inc., Pro-J Pharma Inc., Biomed (2002) Inc. and Alliance Pharma SENCRL, which are engaged in provision of pharmacy services.
Company Coordinates 
Company Details
1351, rue Notre-Dame Est, Suite 300 , THETFORD MINES QC : G6G 0G5
Registrar Details






